Bieber, Thomas

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003

Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology

Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research

Cited by 2,391

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 2,110

Atopic Dermatitis

Bieber, T. (2008) · New England Journal of Medicine

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 1,780

Atopic dermatitis

Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 1,549

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 1,181

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 684

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., et al. (2012) · Journal of Allergy and Clinical Immunology

Allergic Rhinitis and SensitizationAsthma and respiratory diseases

Cited by 623

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Bieber, T. (2022) · Nature Reviews Drug Discovery

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 623

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 522

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI).

Bieber, T., de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R., Ring, J., Hanau, D., & de la Salle, C. (1992) · The Journal of experimental medicine

Mast cells and histamineMonoclonal and Polyclonal Antibodies Research

Cited by 481

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 460

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Reich, K., Teixeira, H. D., de Bruin-Weller, M., Bieber, T., Soong, W., Kabashima, K., Werfel, T., Zeng, J., Huang, X., Hu, X., et al. (2021) · The Lancet

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 402

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Simpson, E. L., Lacour, J. ‐., Spelman, L., Galimberti, R., Eichenfield, L. F., Bissonnette, R., King, B. A., Thyssen, J. P., Silverberg, J. I., Bieber, T., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 396

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

Bieber, T. (2020) · Allergy

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 382

Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 350

Microbiome in healthy skin, update for dermatologists

Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L. F., Martin, R., & Bieber, T. (2016) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesGut microbiota and health

Cited by 292

Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

Ständer, S., Yosipovitch, G., Legat, F. J., Lacour, J.-P., Paul, C., Narbutt, J., Bieber, T., Misery, L., Wollenberg, A., Reich, A., et al. (2020) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 281

The impact of airborne pollution on skin

Araviiskaia, E., Berardesca, E., Bieber, T., Gontijo, G., Sanchez Viera, M., Marrot, L., Chuberre, B., & Dreno, B. (2019) · Journal of the European Academy of Dermatology and Venereology

Air Quality and Health ImpactsSkin Protection and Aging

Cited by 214

Mechanism of HBD-3 deficiency in atopic dermatitis

Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology

Dermatology and Skin DiseasesAntimicrobial Peptides and Activities

Cited by 208

Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis

Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M. (2005) · Journal of Investigative Dermatology

Dermatology and Skin DiseasesAntimicrobial Peptides and Activities

Cited by 193

Therapeutic pipeline for atopic dermatitis: End of the drought?

Paller, A. S., Kabashima, K., & Bieber, T. (2017) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 192

FcεRI engagement of Langerhans cell–like dendritic cells and inflammatory dendritic epidermal cell–like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro

Novak, N., Valenta, R., Bohle, B., Laffer, S., Haberstok, J., Kraft, S., & Bieber, T. (2004) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesImmunotherapy and Immune Responses

Cited by 189

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Bieber, T., Thyssen, J. P., Reich, K., Simpson, E. L., Katoh, N., Torrelo, A., De Bruin‐Weller, M., Thaci, D., Bissonnette, R., Gooderham, M., et al. (2021) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesDrug-Induced Adverse Reactions

Cited by 152

Does “autoreactivity” play a role in atopic dermatitis?

Tang, T. S., Bieber, T., & Williams, H. C. (2012) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 146